Allphase Clinical Research was acquired by Calian Group Ltd. in January 2020. Allphase Clinical Research, a Calian company, is a full-service clinical research organization, including regulatory affairs, project management, clinical monitoring, data management, quality assurance auditing, drug safety, and medical writing. Allphase provides Phase II to IV support throughout a wide range of therapeutic areas, with a predominant focus in oncology, CNS, and critical care diseases. Allphase provides integrative and strategic clinical trial services that allow our international partners to realize the advantages of conducting clinical trials in North America, while reinforcing their global development capabilities.